Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes.
Shetty
Greeshma K
GK
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA.
Economides
Panayiotis A
PA
Horton
Edward S
ES
Mantzoros
Christos S
CS
Veves
Aristidis
A
D052242:Adiponectin; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000069059:Atorvastatin; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D002097:C-Reactive Protein / Q000032:analysis; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis* / Q000453:epidemiology; D004311:Double-Blind Method; D005260:Female; D006538:Heptanoic Acids / Q000627:therapeutic use*; D006729:Hormones, Ectopic / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D018836:Inflammation Mediators / Q000097:blood*; D036341:Intercellular Signaling Peptides and Proteins / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011236:Prediabetic State / Q000175:diagnosis*; D011237:Predictive Value of Tests; D011336:Probability; D011379:Prognosis; D011758:Pyrroles / Q000627:therapeutic use*; D012016:Reference Values; D052243:Resistin; D018570:Risk Assessment; D017678:Sex Distribution; D014655:Vascular Resistance
D052242:Adiponectin; D015415:Biomarkers; D006538:Heptanoic Acids; D006729:Hormones, Ectopic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D018836:Inflammation Mediators; D036341:Intercellular Signaling Peptides and Proteins; D011758:Pyrroles; C499624:RETN protein, human; D052243:Resistin; D002097:C-Reactive Protein; D000069059:Atorvastatin